These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1013 related articles for article (PubMed ID: 18305268)

  • 1. Systemic lupus erythematosus.
    Rahman A; Isenberg DA
    N Engl J Med; 2008 Feb; 358(9):929-39. PubMed ID: 18305268
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus.
    Huggins JL; Brunner HI
    J Pediatr; 2006 May; 148(5):571-3. PubMed ID: 16737861
    [No Abstract]   [Full Text] [Related]  

  • 3. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLE Conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):163. PubMed ID: 20061717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
    Takasaki Y
    Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839
    [No Abstract]   [Full Text] [Related]  

  • 6. New therapies for systemic lupus erythematosus: cellular targets.
    Looney RJ; Anolik J; Sanz I
    Rheum Dis Clin North Am; 2006 Feb; 32(1):201-15, xi. PubMed ID: 16504831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
    Vallerskog T; Gunnarsson I; Widhe M; Risselada A; Klareskog L; van Vollenhoven R; Malmström V; Trollmo C
    Clin Immunol; 2007 Jan; 122(1):62-74. PubMed ID: 17046329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in systemic lupus erythematosus.
    Abud-Mendoza C; González-Amaro R
    Lupus; 2010 Apr; 19(5):658. PubMed ID: 19900978
    [No Abstract]   [Full Text] [Related]  

  • 9. B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE.
    Iwata S; Saito K; Tokunaga M; Tanaka Y
    Ann Rheum Dis; 2012 Oct; 71(10):1749-50. PubMed ID: 22586167
    [No Abstract]   [Full Text] [Related]  

  • 10. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP; Rosado MM; Carsetti R; Valesini G
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus in children: current and emerging therapies.
    Macdermott EJ; Adams A; Lehman TJ
    Lupus; 2007; 16(8):677-83. PubMed ID: 17711907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunological dysfunction in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1982 Feb; 23(1):12-8. PubMed ID: 6214005
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.
    Lee JW; Kim HA; Sung JM; Suh CH
    Lupus; 2010 Feb; 19(2):227-8. PubMed ID: 19884220
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic lupus erythematosus conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
    Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA
    Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
    Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I
    Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin and significance of autoantibodies.
    Dighiero G; Kaushik A; Poncet P; Ge XR
    Concepts Immunopathol; 1987; 4():42-76. PubMed ID: 3297339
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
    Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
    Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 51.